Tuesday, February 07, 2017
Comprehensive New Study Finds that Yoga Can Be Helpful for Low Back Pain
Over the course of their lives, about 80 percent of Americans will suffer from back pain at one time or another. A recent study found that more than a third of adults say that low back pain has affected their ability to perform the tasks of daily living, exercise, or sleep. Treating this pain remains a difficult problem, and for millions of people the pain is chronic.
Monday, February 06, 2017
Teams of Top Scientists to Join University of Maryland School of Medicine as Major Recruitment Initiative Has Strong Start
The University of Maryland School of Medicine (UM SOM) announced today the successful recruitment of a broad slate of top scientists, as the first part of the School of Medicine’s bold new recruitment initiative called “STRAP” (Special Trans-Disciplinary Recruitment Award Program).
Tuesday, January 17, 2017
Special Issue of Pathogens and Disease Highlights Innovative Research by Scientists at the University of Maryland School of Medicine in Collaboration with UM School of Dentistry
New research by scientists at the University of Maryland School of Medicine (UM SOM) and the University of Maryland School of Dentistry (UM SOD), is highlighted in a special issue of Pathogens and Disease.
Friday, January 13, 2017
Scientists Identify Vaccination as the Most Cost-Effective Strategy to Sharply Reduce Rabies Deaths in India
Every year in India, 20,000 people are estimated to die from rabies. Most of the victims are children. Nearly all of the deaths occur after victims are bitten by rabid dogs. For years, experts have debated the best strategy to reduce this burden.
Thursday, January 12, 2017
Department of Surgery at the University of Maryland School of Medicine Forms New Executive Committee to Provide “Visionary Governance”
University of Maryland School of Medicine Department of Surgery Chairman Stephen Bartlett, MD, announced today the formation of a new Department of Surgery Executive Committee. The new committee, which draws from the Department’s top clinical and research faculty leadership, will provide strategic oversight and advice on ongoing departmental operations and initiatives with the goal of advancing innovation, growth, and visibility.
Wednesday, January 11, 2017
University of Maryland Medical Center Offers Genetic Testing as Standard of Care to Help Improve Outcomes for Heart Stent Patients
The University of Maryland Medical Center (UMMC) is now offering a simple genetic test to patients who receive heart stents to determine whether they have a genetic deficiency that affects how they respond to a common drug to prevent blood clots. Patients are typically given the medication, clopidogrel, to prevent cardiovascular events after having a stent placed in a coronary artery to treat a blockage.
Thursday, January 05, 2017
For the First Time, Researchers Identify Key Proteins That May Make Zika So Deadly
Until it burst onto the scene earlier this year, Zika was an obscure, little-known virus. As a result, scientists know little about how it works. Over the past year, they have learned that it can cause a range of dangerous health problems, including birth defects such as microcephaly and neurological problems such as Guillain-Barré syndrome. But they don’t know which Zika protein or proteins are causing harm, or exactly how these proteins cause damage.
Wednesday, January 04, 2017
Honoring a Hero: Dr. Thomas Scalea, Physician-in-Chief at the R Adams Cowley Shock Trauma Center, Marks 20 Years at the University of Maryland
Under his leadership, Shock Trauma has grown tremendously – from the construction of the cutting-edge Critical Care Tower to the expansion of hands-on training opportunities for physicians, nurses and medical students.
Friday, December 23, 2016
Trial Results Confirm Ebola Vaccine Provides High Protection Against Disease
An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to a new study that included researchers from the University of Maryland School of Medicine (UM SOM).
Tuesday, December 20, 2016
First U.S. Babies Treated in Unique Study of Adult Stem Cell Therapy for Congenital Heart Disease
In a first-in-children randomized clinical study, medical researchers at the University of Maryland School of Medicine (UM SOM) and the Interdisciplinary Stem Cell Institute (ISCI) at the University of Miami Miller School of Medicine have begun testing to see whether adult stem cells derived from bone marrow benefit children with the congenital heart defect hypoplastic left heart syndrome (HLHS).